X

Health Care

Abiomed’s stock plunges to new 52-week low on Q4 revenue miss

Abiomed’s (NASDAQ: ABMD) stock plunged about 17% in the pre-market trading as the company failed to meet top-line estimates. It…

Exelixis tops Q1 earnings and revenue estimates

Exelixis Inc. (NASDAQ: EXEL) surpassed Q1 earnings and revenue projections. The company reported earnings of $0.27 per share on revenue…

Acorda Therapeutics stock sinks to 13-year low

Acorda Therapeutics (NASDAQ: ACOR) stock tumbled to a 13-year low of $10.02 on Wednesday as investors remained concerned about the…

Novavax Q1 earnings preview: Future plans on ResVax and NanoFlu will be the key focus points

Novavax Inc (NASDAQ: NVAX) is slated to report its first quarter 2019 earnings results after market closes on Thursday. Novavax…

Earnings preview: New product launches in focus as Teva gets ready for Q1 report

Teva Pharmaceutical (NYSE: TEVA) has long endued uncertainties in business even as the generic drug maker continued its efforts to…

Gilead Sciences earnings preview: What to expect in Q1

Gilead Sciences (NASDAQ: GILD) has tested its investors enough lately. The stock has increased just 2.5% in the year-to-date period,…

CVS Health posts upbeat Q1 earnings, Q2 forecast

CVS Health Corporation (NYSE: CVS) reported a 43% jump in earnings for the first quarter of 2019 helped by the…

Earnings: Humana Q1 profit climbs on strength of Medicare biz; lifts FY19 guidance

Healthcare service provider Humana, Inc. (NYSE: HUM) Wednesday reported better than expected earnings and revenues for the first quarter, helped…

Amarin Corp tops the market in Q1 on Vascepa strength

Amarin Corporation (NASDAQ: AMRN) on Wednesday said its revenues soared 67% to $73.3 million, riding on the strong demand for…

Vertex Pharmaceuticals’ Q1 results beat estimates

Vertex Pharmaceuticals (NASDAQ: VRTX) topped market expectations on revenue and earnings for the first quarter of 2019. Shares were up…